{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:56:06Z","timestamp":1782928566810,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 834\/3"],"award-info":[{"award-number":["SFB 834\/3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["Z01 ES025034"],"award-info":[{"award-number":["Z01 ES025034"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jbc.2023.103049","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T02:08:56Z","timestamp":1677031736000},"page":"103049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts"],"prefix":"10.1016","volume":"299","author":[{"given":"Matthew L.","family":"Edin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artiom","family":"Gruzdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alyce","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan P.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred B.","family":"Lih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"DeGraff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-3635","authenticated-orcid":false,"given":"Ingrid","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl C.","family":"Zeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.103049_bib1","doi-asserted-by":"crossref","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function","volume":"292","author":"Spector","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.prostaglandins.2011.09.001","article-title":"CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?","volume":"96","author":"Westphal","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jbc.2023.103049_bib3","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1074\/jbc.RA117.000298","article-title":"Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia","volume":"293","author":"Edin","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.103049_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jbc.2023.103049_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/FJC.0b013e3181c37d69","article-title":"Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury","volume":"55","author":"Chaudhary","year":"2010","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jbc.2023.103049_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.RES.0000237390.92932.37","article-title":"Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function","volume":"99","author":"Seubert","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2023.103049_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvinukova","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.103049_bib8","doi-asserted-by":"crossref","first-page":"H1883","DOI":"10.1152\/ajpheart.00514.2007","article-title":"Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse","volume":"293","author":"Banerjee","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib9","doi-asserted-by":"crossref","first-page":"H491","DOI":"10.1152\/ajpheart.00927.2005","article-title":"Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition","volume":"290","author":"Larsen","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/002215540405200403","article-title":"Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues","volume":"52","author":"Enayetallah","year":"2004","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.jbc.2023.103049_bib11","doi-asserted-by":"crossref","first-page":"F720","DOI":"10.1152\/ajprenal.00165.2003","article-title":"Vascular localization of soluble epoxide hydrolase in the human kidney","volume":"286","author":"Yu","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1369\/jhc.5A6808.2005","article-title":"Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues","volume":"54","author":"Enayetallah","year":"2006","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.jbc.2023.103049_bib13","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1073\/pnas.261710799","article-title":"Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation","volume":"99","author":"Davis","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.103049_bib14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.10-171488","article-title":"Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice","volume":"25","author":"Deng","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2023.103049_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/FJC.0b013e318185fa3c","article-title":"Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model","volume":"52","author":"Ulu","year":"2008","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jbc.2023.103049_bib16","doi-asserted-by":"crossref","first-page":"15983","DOI":"10.1074\/jbc.M100439200","article-title":"Activation of galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids","volume":"276","author":"Node","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.103049_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.RES.78.3.415","article-title":"Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors","volume":"78","author":"Campbell","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2023.103049_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.05.017","article-title":"Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia\/reperfusion injury","volume":"82","author":"Seubert","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jbc.2023.103049_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2012.04.008","article-title":"Role of PI3Kalpha and sarcolemmal ATP-sensitive potassium channels in epoxyeicosatrienoic acid mediated cardioprotection","volume":"53","author":"Batchu","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.jbc.2023.103049_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1517\/14728222.9.3.447","article-title":"Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition","volume":"9","author":"Murphy","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jbc.2023.103049_bib21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1113\/jphysiol.2001.012896","article-title":"Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes","volume":"537","author":"Lu","year":"2001","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib22","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3389\/fphar.2018.01572","article-title":"Deficiency of soluble epoxide hydrolase protects cardiac function impaired by LPS-induced acute inflammation","volume":"9","author":"Samokhvalov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2023.103049_bib23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ijbiomac.2021.04.187","article-title":"Natural soluble epoxide hydrolase inhibitors from Alisma orientale and their potential mechanism with soluble epoxide hydrolase","volume":"183","author":"Zhao","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jbc.2023.103049_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2023.103049_bib25","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","article-title":"Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy","volume":"168","author":"Althurwi","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2023.103049_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.prostaglandins.2018.07.005","article-title":"Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome","volume":"138","author":"Oni-Orisan","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jbc.2023.103049_bib27","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/hmg\/ddl085","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study","volume":"15","author":"Lee","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2023.103049_bib28","doi-asserted-by":"crossref","first-page":"40504","DOI":"10.1074\/jbc.M008106200","article-title":"Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation","volume":"275","author":"Sinal","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.103049_bib29","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1096\/fj.11-188300","article-title":"Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart","volume":"25","author":"Edin","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2023.103049_bib30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.RES.0000139436.89654.c8","article-title":"Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42\/p44 MAPK pathway","volume":"95","author":"Seubert","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2023.103049_bib31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/01.RES.0000018162.87285.F8","article-title":"14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries","volume":"90","author":"Gauthier","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2023.103049_bib32","doi-asserted-by":"crossref","first-page":"H2148","DOI":"10.1152\/ajpheart.00074.2007","article-title":"COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia","volume":"293","author":"Birkenmeier","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00395-014-0414-0","article-title":"Hypoxic preconditioning protects rat hearts against ischemia-reperfusion injury via the arachidonate12-lipoxygenase\/transient receptor potential vanilloid 1 pathway","volume":"109","author":"Lu","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jbc.2023.103049_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1752-8062.2011.00294.x","article-title":"Cytosolic phospholipase A(2)alpha protects against ischemia\/reperfusion injury in the heart","volume":"4","author":"Kerkela","year":"2011","journal-title":"Clin. Transl Sci."},{"key":"10.1016\/j.jbc.2023.103049_bib35","doi-asserted-by":"crossref","first-page":"22231","DOI":"10.1074\/jbc.C300033200","article-title":"Cardiac ischemia activates calcium-independent phospholipase A2beta, precipitating ventricular tachyarrhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition","volume":"278","author":"Mancuso","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.103049_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1074\/jbc.RA117.000405","article-title":"Heart failure-induced activation of phospholipase iPLA(2)gamma generates hydroxyeicosatetraenoic acids opening the mitochondrial permeability transition pore","volume":"293","author":"Moon","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.103049_bib37","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/0006-291X(92)91877-S","article-title":"Arachidonic acid epoxygenase: structural characterization and quantification of epoxyeicosatrienoates in plasma","volume":"182","author":"Karara","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl","key":"10.1016\/j.jbc.2023.103049_bib38","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50 Suppl","author":"Spector","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jbc.2023.103049_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s43188-021-00088-z","article-title":"Regulation of cardiovascular biology by microsomal epoxide hydrolase","volume":"37","author":"Edin","year":"2021","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.jbc.2023.103049_bib40","doi-asserted-by":"crossref","first-page":"H2412","DOI":"10.1152\/ajpheart.00527.2004","article-title":"Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels","volume":"287","author":"Fang","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib41","doi-asserted-by":"crossref","first-page":"21618","DOI":"10.1074\/jbc.M113.481077","article-title":"Diminished acyl-CoA synthetase isoform 4 activity in INS 832\/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion","volume":"288","author":"Klett","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.103049_bib42","doi-asserted-by":"crossref","first-page":"H2306","DOI":"10.1152\/ajpheart.00448.2002","article-title":"Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide","volume":"283","author":"Fang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/tx990162c","article-title":"Toxicity of epoxy fatty acids and related compounds to cells expressing human soluble epoxide hydrolase","volume":"13","author":"Greene","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jbc.2023.103049_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/cvr\/22.3.213","article-title":"Cardiovascular effects of leukotoxin (9, 10-epoxy-12-octadecenoate) and free fatty acids in dogs","volume":"22","author":"Fukushima","year":"1988","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jbc.2023.103049_bib45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2010.09.009","article-title":"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids","volume":"1814","author":"Konkel","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2023.103049_bib46","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1113\/expphysiol.2007.038166","article-title":"The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents","volume":"92","author":"Hercule","year":"2007","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib47","doi-asserted-by":"crossref","first-page":"114866","DOI":"10.1016\/j.bcp.2021.114866","article-title":"Epoxylipids and soluble epoxide hydrolase in heart diseases","volume":"195","author":"Imig","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2023.103049_bib48","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1096\/fj.10-160119","article-title":"Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice","volume":"24","author":"Lee","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2023.103049_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.prostaglandins.2017.09.001","article-title":"Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): role of adenosine A2A receptor and plasma oxylipins","volume":"131","author":"Hanif","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jbc.2023.103049_bib50","doi-asserted-by":"crossref","first-page":"R676","DOI":"10.1152\/ajpregu.00237.2016","article-title":"Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARgamma","volume":"311","author":"Hanif","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.jbc.2023.103049_bib51","article-title":"Vascular endothelial over-expression of human soluble epoxide hydrolase (Tie2-sEH Tr) attenuates coronary reactive hyperemia in mice: role of oxylipins and omega-hydroxylases","volume":"12","author":"Hanif","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2023.103049_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/micc.12255","article-title":"Endothelium-derived hyperpolarization and coronary vasodilation: diverse and integrated roles of epoxyeicosatrienoic acids, hydrogen peroxide, and gap junctions","volume":"23","author":"Ellinsworth","year":"2016","journal-title":"Microcirculation"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823001813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823001813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:34:22Z","timestamp":1758242062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823001813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0021925823001813"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.103049","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.103049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"103049"}}